Related references
Note: Only part of the references are listed.Risk factors and outcome of extended-spectrum beta-lactamase-producing Enterobacter cloacae bloodstream infections
Zubair A. Qureshi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Positive Extended-Spectrum-β-Lactamase (ESBL) Screening Results May Be Due to AmpC β-Lactamases More Often than to ESBLs
G. K. Munier et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
The changing epidemiology of resistance
Peter M. Hawkey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Novel CTX-M β-lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China
Wen'en Liu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Prevalence and clonality of extended-spectrum beta-lactamases in Asia
P. M. Hawkey
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe
R. Canton et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
The continuing challenge of ESBLs
Federico Perez et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Spread of extended-spectrum β-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal
Nuno Mendonca et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary health region: Emergence of CTX-M-15-producing isolates
Johann D. D. Pitout et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China
Yunsong Yu et al.
JOURNAL OF INFECTION (2007)
Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli
Cao Bin et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2006)
Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum beta-lactamases
N Woodford et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Phenotypic and molecular detection of CTX-M-β-lactamases produced by Escherichia coli and Klebsiella spp.
JDD Pitout et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy
CI Kang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Growing group of extended-spectrum beta-lactamases: The CTX-M enzymes
R Bonnet
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Investigation of extended-spectrum β-lactamase in Klebsiellae pneumoniae and Escherichia coli from China
ZZ Xiong et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2002)
TEM derivative-producing Enterobacter aerogenes strains:: Dissemination of a prevalent clone
P Dumarche et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases:: Implications for the clinical microbiology laboratory
DL Paterson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Are SHV β-lactamases universal in Klebsiella pneumoniae?
GS Babini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae
S Hernández-Allés et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)